


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
SNY
Sanofi
$43.95

Login to see Sanofi (SNY) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market
Risk Analysis

Downgraded on weak valued
SNY Price Performance
$42.85 (+2.57%)
$44.06 (-0.25%)
$46.59 (-5.67%)
$48.37 (-9.14%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
SNY Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SNY Street Sentiment is bullish and have positive views on the near-term outlook
SNY has Low risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Dec 30, 2025
Reiterate
its Buy
Jefferies
Jan 26, 2026
Downgrade
Neutral
UBS
Apr 23, 2026
Downgrade
Neutral
BNP Paribas
Apr 20, 2026
Upgrade
Neutral
Morgan Stanley
Dec 16, 2025
Reiterate
Buy
INTESA SANPAOLO EQUITY RESEARCH
ADAG
Adagene Inc. American
3.35
-1.47%
REGN
Regeneron Pharma
611.25
-0.80%
NVS
Novartis AG
149.42
+0.34%
MRK
Merck Company
118.87
-0.46%
TEVA
Teva Pharma
34.03
-1.22%
What is SNY current stock price?
What is SNY current Stock IQ?
What is SNY RSI signal right now?
What is SNY analyst price target and upside potential?
What do analysts say about SNY stock?
What is SNY momentum trend right now?
What are SNY stock strengths?
What is SNY Risk Level?
Should I buy SNY stock right now?
Is SNY a Strong Buy right now?
What is SNY market cap and volume?
What factors influence SNY's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
SNY
Sanofi
Current Price
$43.95
ADAG
Adagene Inc. American
3.35
-1.47%
REGN
Regeneron Pharma
611.25
-0.80%
NVS
Novartis AG
149.42
+0.34%
MRK
Merck Company
118.87
-0.46%
TEVA
Teva Pharma
34.03
-1.22%

SNY Price Performance
$42.85 (+2.57%)
$44.06 (-0.25%)
$46.59 (-5.67%)
$48.37 (-9.14%)
SNY Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
SNY Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SNY Street Sentiment is bullish and have positive views on the near-term outlook
SNY has Low risk level

Overall Wall Street Rating
SNY Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market
Risk Analysis

Downgraded on weak valued
SNY Trading Signals
SNY crossed below its 50-day MA ($45.19) at $44.73. Potential bearish reversal.
SNY RSI crossed above 50, breaking into bullish territory (RSI: 53.6 vs previous 48.7)
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.